125 related articles for article (PubMed ID: 30783647)
21. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y
PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831
[TBL] [Abstract][Full Text] [Related]
22. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
[TBL] [Abstract][Full Text] [Related]
23. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
[TBL] [Abstract][Full Text] [Related]
24. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
25. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
27. The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.
Luo J; Li J; Shen X; Hu X; Fang Z; Lv X; Zhou S
Int J Cardiol; 2013 Sep; 167(5):2350-3. PubMed ID: 23194788
[No Abstract] [Full Text] [Related]
28. Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials.
Pan Y; Tan Y; Li B; Li X
Lipids Health Dis; 2015 Aug; 14():97. PubMed ID: 26306625
[TBL] [Abstract][Full Text] [Related]
29. [Administration of statins during the acute phase of acute coronary syndrome].
Ruiz-Bailén M
Med Intensiva; 2010; 34(1):56-63. PubMed ID: 19875196
[TBL] [Abstract][Full Text] [Related]
30. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
Zemánek D; Branny M; Martinkovičová L; Hájek P; Malý M; Tesař D; Tomašov P; Veselka J
Int J Cardiol; 2013 Oct; 168(3):2494-7. PubMed ID: 23597577
[TBL] [Abstract][Full Text] [Related]
31. Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): rationale and design.
Miyauchi K; Kimura T; Morimoto T; Nakagawa Y; Yamagishi M; Ozaki Y; Hiro T; Daida H; Matsuzaki M
Circ J; 2006 Dec; 70(12):1624-8. PubMed ID: 17127811
[TBL] [Abstract][Full Text] [Related]
32. Recommendations of statin treatment after acute coronary syndrome: Hungarian experiences.
Mark L; Janosi A; Ferenci T; Toth PP
Atherosclerosis; 2020 Jun; 303():53-54. PubMed ID: 32284151
[No Abstract] [Full Text] [Related]
33. Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome.
Schwartz GG; Fayyad R; Szarek M; DeMicco D; Olsson AG
Eur J Prev Cardiol; 2017 Aug; 24(12):1294-1296. PubMed ID: 28504565
[TBL] [Abstract][Full Text] [Related]
34. Efficacy Evaluation of High-Dose Atorvastatin Pretreatment in Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
Ma Y; Xiang C; Zhang B
Med Sci Monit; 2018 Dec; 24():9354-9363. PubMed ID: 30580373
[TBL] [Abstract][Full Text] [Related]
35. Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction.
García-Méndez RC; Almeida-Gutierrez E; Serrano-Cuevas L; Sánchez-Díaz JS; Rosas-Peralta M; Ortega-Ramirez JA; Palomo-Villada JA; Isordia-Salas I; Alonso-Bravo RM; Borrayo-Sanchez G
Arch Med Res; 2018 Nov; 49(8):620-629. PubMed ID: 30446246
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Navarese EP; Kowalewski M; Andreotti F; van Wely M; Camaro C; Kolodziejczak M; Gorny B; Wirianta J; Kubica J; Kelm M; de Boer MJ; Suryapranata H
Am J Cardiol; 2014 May; 113(10):1753-64. PubMed ID: 24792742
[TBL] [Abstract][Full Text] [Related]
37. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of high atorvastatin dose reloading prior to percutaneous coronary intervention.
Katsiki N; Athyros VG; Karagiannis A
Curr Med Res Opin; 2014 Jan; 30(1):55. PubMed ID: 24024869
[No Abstract] [Full Text] [Related]
39. What Is the Appropriate Duration of High-Dose Atorvastatin Therapy Post-Acute Coronary Syndrome?
Goriacko P; Andersen M; Fazylov R; Plakogiannis R
J Pharm Pract; 2015 Dec; 28(6):555-60. PubMed ID: 25107416
[TBL] [Abstract][Full Text] [Related]
40. [Effect of intensive treatment with atorvastatin versus standard doses of statins on the risk of stroke. A meta-analysis from five randomized trials including 25,709 patients].
Fernándezde Bobadilla J; Moreno R; Fernández C; Martínez A; Sánchez-Maestre C; Ezpeleta-Echevarri D
Rev Neurol; 2009 Jun 1-15; 48(11):561-5. PubMed ID: 19472152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
